| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study
|
Charpentier, B
|
|
2003
|
35 |
3S |
p. S58-S61
4 p.
|
artikel
|
| 2 |
Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation
|
Legendre, C
|
|
2003
|
35 |
3S |
p. S151-S153
3 p.
|
artikel
|
| 3 |
Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a Single-Center experience
|
Kuypers, D.R.J
|
|
2003
|
35 |
3S |
p. S138-S142
5 p.
|
artikel
|
| 4 |
CME—quiz
|
|
|
2003
|
35 |
3S |
p. S235-S240
6 p.
|
artikel
|
| 5 |
Conversion to sirolimus in solid organ transplantation: a Single-Center experience
|
Egidi, M.F
|
|
2003
|
35 |
3S |
p. S131-S137
7 p.
|
artikel
|
| 6 |
Dear Colleague:
|
Kahan, Barry D.
|
|
2003
|
35 |
3S |
p. ix-
1 p.
|
artikel
|
| 7 |
De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco
|
Vincenti, F.
|
|
2003
|
35 |
3S |
p. S183-S186
4 p.
|
artikel
|
| 8 |
Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine
|
Ponticelli, C
|
|
2003
|
35 |
3S |
p. S62-S63
2 p.
|
artikel
|
| 9 |
Evaluation
|
|
|
2003
|
35 |
3S |
p. S241-
1 p.
|
artikel
|
| 10 |
Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience
|
Wiseman, A.C
|
|
2003
|
35 |
3S |
p. S122-S124
3 p.
|
artikel
|
| 11 |
How should sirolimus be used in clinical practice?
|
Johnson, R.W.G
|
|
2003
|
35 |
3S |
p. S79-S83
5 p.
|
artikel
|
| 12 |
Kidney transplantation without calcineurin inhibitors using sirolimus
|
Stegall, M.D
|
|
2003
|
35 |
3S |
p. S125-S127
3 p.
|
artikel
|
| 13 |
Minimizing calcineurin inhibitor drugs in renal transplantation
|
Flechner, S.M
|
|
2003
|
35 |
3S |
p. S118-S121
4 p.
|
artikel
|
| 14 |
Molecular actions of sirolimus: sirolimus and mTor
|
Kirken, R.A
|
|
2003
|
35 |
3S |
p. S227-S230
4 p.
|
artikel
|
| 15 |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients
|
Lo, A
|
|
2003
|
35 |
3S |
p. S105-S108
4 p.
|
artikel
|
| 16 |
Optimizing the long-term outcome of renal transplants: opportunities created by sirolimus
|
Chapman, J.R
|
|
2003
|
35 |
3S |
p. S67-S72
6 p.
|
artikel
|
| 17 |
Preclinical results of sirolimus treatment in transplant models
|
Stepkowski, S.M
|
|
2003
|
35 |
3S |
p. S219-S226
8 p.
|
artikel
|
| 18 |
Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation
|
MacDonald, A.S
|
|
2003
|
35 |
3S |
p. S201-S208
8 p.
|
artikel
|
| 19 |
Rapamycin: signaling in vascular smooth muscle
|
Marks, A.R
|
|
2003
|
35 |
3S |
p. S231-S233
3 p.
|
artikel
|
| 20 |
Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients
|
Russ, G.R
|
|
2003
|
35 |
3S |
p. S115-S117
3 p.
|
artikel
|
| 21 |
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty
|
Tedesco Silva Jr., H
|
|
2003
|
35 |
3S |
p. S177-S180
4 p.
|
artikel
|
| 22 |
Sirolimus and islet transplants
|
Hering, B.J.
|
|
2003
|
35 |
3S |
p. S187-S190
4 p.
|
artikel
|
| 23 |
Sirolimus: a single center experience in combination with calcineurin inhibitors
|
Masterson, R
|
|
2003
|
35 |
3S |
p. S99-S104
6 p.
|
artikel
|
| 24 |
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation
|
Formica Jr., R.N
|
|
2003
|
35 |
3S |
p. S95-S98
4 p.
|
artikel
|
| 25 |
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients
|
Morrisett, J.D
|
|
2003
|
35 |
3S |
p. S143-S150
8 p.
|
artikel
|
| 26 |
Sirolimus experience at a Swedish transplantation center
|
Wilczek, H.E
|
|
2003
|
35 |
3S |
p. S84-S88
5 p.
|
artikel
|
| 27 |
Sirolimus immunotherapy: the Albany Medical Center experience
|
Escobar, F.S
|
|
2003
|
35 |
3S |
p. S109-S112
4 p.
|
artikel
|
| 28 |
Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients—a single center experience
|
El-Sabrout, R
|
|
2003
|
35 |
3S |
p. S89-S94
6 p.
|
artikel
|
| 29 |
Sirolimus in liver transplantation
|
Trotter, J.F
|
|
2003
|
35 |
3S |
p. S193-S200
8 p.
|
artikel
|
| 30 |
Sirolimus in pediatric transplant recipients
|
Sindhi, R
|
|
2003
|
35 |
3S |
p. S113-S114
2 p.
|
artikel
|
| 31 |
Sirolimus: its discovery, biological properties, and mechanism of action
|
Sehgal, S.N
|
|
2003
|
35 |
3S |
p. S7-S14
8 p.
|
artikel
|
| 32 |
Sirolimus monotherapy following Campath-1H induction
|
Rao, V
|
|
2003
|
35 |
3S |
p. S128-S130
3 p.
|
artikel
|
| 33 |
Sirolimus therapy in cardiac transplantation
|
Radovancevic, B
|
|
2003
|
35 |
3S |
p. S171-S176
6 p.
|
artikel
|
| 34 |
Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
|
Morelon, E
|
|
2003
|
35 |
3S |
p. S52-S57
6 p.
|
artikel
|
| 35 |
Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience
|
Kahan, B.D
|
|
2003
|
35 |
3S |
p. S25-S34
10 p.
|
artikel
|
| 36 |
Ten years of sirolimus therapy in orthotopic liver transplant recipients
|
Neff, G.W
|
|
2003
|
35 |
3S |
p. S209-S216
8 p.
|
artikel
|
| 37 |
The development of immunosuppression: the rapamycin milestone
|
Calne, R.Y.
|
|
2003
|
35 |
3S |
p. S15-S17
3 p.
|
artikel
|
| 38 |
The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation
|
Camardo, J
|
|
2003
|
35 |
3S |
p. S18-S24
7 p.
|
artikel
|
| 39 |
Therapeutic monitoring of sirolimus: its contribution to optimal prescription
|
Holt, D.W
|
|
2003
|
35 |
3S |
p. S157-S161
5 p.
|
artikel
|
| 40 |
Tribute to Suren Sehgal
|
Camardo, Joseph
|
|
2003
|
35 |
3S |
p. S2-S4
3 p.
|
artikel
|
| 41 |
Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation
|
Morales, J.M
|
|
2003
|
35 |
3S |
p. S154-S156
3 p.
|
artikel
|
| 42 |
Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation
|
Kahan, B.D
|
|
2003
|
35 |
3S |
p. S37-S51
15 p.
|
artikel
|
| 43 |
Use of rapamycin-impregnated stents in coronary arteries
|
Sousa, J.E
|
|
2003
|
35 |
3S |
p. S165-S170
6 p.
|
artikel
|
| 44 |
Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients
|
Hricik, D.E
|
|
2003
|
35 |
3S |
p. S73-S78
6 p.
|
artikel
|
Tijdschrift beschrijving